Why Shares Of Cogent Biosciences Are Trading Higher

Cogent Biosciences, Inc. COGT shares are trading higher after the company reported initial data from its ongoing Phase 2 APEX clinical trial.

All patients treated with bezuclastinib achieved greater than or equal to 50% reduction in serum tryptase, with a median reduction of 89%, regardless of prior KIT D816V inhibitor treatment.

Andrew Robbins, Chief Executive Officer at Cogent Biosciences said, "We are very excited to present initial clinical data from the APEX study of bezuclastinib in advanced systemic mastocytosis."

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases.

The stock was trading about 89.5% higher at $9.40 per share on Friday at the time of publication.

 

Posted In: why it's movingSmall CapMoversTrading Ideas

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.